You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME

Penile Rehabilitation Following Radical Prostatectomy

  • Authors: John P. Mulhall, MSc, MD
  • THIS ACTIVITY HAS EXPIRED
Start Activity


Target Audience and Goal Statement

This activity is intended for urologists.

The goal of this activity is to bring clinicians who treat men who have undergone radical prostatectomy up to date with the latest research into expediting and optimizing recovery of erectile function.

Upon completion of this activity, participants will be able to:

  1. Review the probable mechanisms of erectile function and sexual dysfunction after radical prostatectomy
  2. Recognize current strategies in expediting the recovery of erectile function after radical prostatectomy
  3. Evaluate recent data on the rehabilitation of sexual function after RP


Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • John P. Mulhall, MSc, MD

    Associate Attending Physician, Memorial Sloan-Kettering Cancer Center, New York, NY

    Disclosures

    Disclosure: John P. Mulhall, MSc, MD, has disclosed no relevant financial relationships.

Editor

  • David McNeel

    Editorial Director, Medscape Urology

    Disclosures

    Disclosure: David McNeel has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™ . Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. Medscape encourages you to complete the Activity Evaluation to provide feedback for future programming.
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CME

Penile Rehabilitation Following Radical Prostatectomy

Authors: John P. Mulhall, MSc, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

processing....

Introduction

Until relatively recently, men undergoing radical prostatectomy (RP) faced the distressing prospect of significant -- if not total -- loss of erectile function. Although the development of nerve-sparing techniques in recent years has improved the long-term prospects that a man might regain a somewhat normal sexual life, some compromise of erectile function is still common. In recent years, researchers have increasingly directed their efforts toward searching for interventions that might improve the speed and extent of recovery of sexual function.

The factors influencing the pace and overall success of rehabilitation are still uncertain. Growing evidence suggests that rehabilitation may be expedited by the early use of vacuum devices, phosphodiesterase (PDE)-5 inhibitors, and intracavernosal and transurethral agents. The push to shorten postsurgical recovery time is not mere impatience -- there is a growing recognition that the sooner the tissues regain function, the less damage they sustain from prolonged disuse. In other words, the earlier that effective measures for rehabilitation are undertaken, the more complete the recovery of sexual function. A number of studies have been done to clarify these issues, and some data are available, but we're still awaiting the release of definitive results. The purpose of this Clinical Update is to acquaint clinicians with progress in this area and with ongoing research.

To appreciate the strategy of penile rehabilitation after RP, several concepts need to be understood -- namely, the pathophysiology of erectile dysfunction (ED) after RP; cavernosal oxygenation; venous leak; the animal data supporting the use of PDE-5 inhibitors as a rehabilitation strategy; and the human data supporting use of PDE-5 inhibitors and intracavernosal injections as a means of preserving erectile tissue health and function.